$ 27.16
Key Takeaways
Risk factor
Low price volatility
Profitability factor
Greatly undervalued vs peers
About
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the...
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD
Target Price
The average target price of FMS is 30 and suggests 10% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation sug